Search

Your search keyword '"Rajasegaran, Vikneswari"' showing total 173 results

Search Constraints

Start Over You searched for: Author "Rajasegaran, Vikneswari" Remove constraint Author: "Rajasegaran, Vikneswari"
173 results on '"Rajasegaran, Vikneswari"'

Search Results

1. Comprehensive molecular characterization of collecting duct carcinoma for therapeutic vulnerability

2. NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer

3. Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing

5. Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma

6. Transcriptomic convergence despite genomic divergence drive field cancerization in synchronous squamous tumors.

8. Correction to: NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer

9. An Optimised Protocol Harnessing Laser Capture Microdissection for Transcriptomic Analysis on Matched Primary and Metastatic Colorectal Tumours

10. A novel genomic panel as an adjunctive diagnostic tool for the characterization and profiling of breast Fibroepithelial lesions

11. Supplementary Figures 1-6 from Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma

12. Data from Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma

13. Supplementary Table 5 from Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma

14. Supplementary Methods and Supplementary Figure and Table Legends from Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma

15. Supplementary Table 4 from Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma

16. Supplementary Table 2 from Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma

17. Supplementary Table 1 from Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma

18. Supplementary Table 4 from Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma

19. Supplementary Table 3 from Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma

20. Supplementary Table 3 from Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma

21. Supplementary Table 1 from Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma

22. Supplementary Figure 1 from Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma

23. Data from Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma

24. Supplementary Table 2 from Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma

25. Data from Inhibition of Gastric Cancer Invasion and Metastasis by PLA2G2A, a Novel β-Catenin/TCF Target Gene

26. Supplementary Information, Figures 1-10 from Inhibition of Gastric Cancer Invasion and Metastasis by PLA2G2A, a Novel β-Catenin/TCF Target Gene

27. Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma

28. A comprehensive next generation sequencing tissue assay for Asian-prevalent cancers—Analytical validation and performance evaluation with clinical samples

29. Clear cell sarcomas of the kidney are characterised by BCOR gene abnormalities, including exon 15 internal tandem duplications and BCOR–CCNB3 gene fusion

33. Transcriptomic convergence despite genomic divergence drive field cancerization in synchronous squamous tumors

34. Rare Occurrence of Aristolochic Acid Mutational Signatures in Oro-Gastrointestinal Tract Cancers

36. Bizarre giant cells in human angiosarcoma exhibit chemoresistance and contribute to poor survival outcomes

37. Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma

38. Whole exome sequencing identifies clinically relevant mutational signatures in resected hepatocellular carcinoma

39. Sequencing and comparative analysis of fugu protocadherin clusters reveal diversity of protocadherin genes among teleosts

40. Recurrent PD-L1 Structural Rearrangements in Natural Killer/T Cell Lymphoma Patients with Complete Response to PD-1 Blockade Therapy

41. Bizarre giant cells in human angiosarcoma exhibit chemoresistance and contribute to poor survival outcomes.

42. Genomic profile of breast sarcomas: a comparison with malignant phyllodes tumours

43. Molecular insights into paediatric breast fibroepithelial tumours

44. Clear cell sarcomas of the kidney are characterised byBCORgene abnormalities, including exon 15 internal tandem duplications andBCOR-CCNB3gene fusion

45. The draft genome of tropical fruit durian (Durio zibethinus)

46. Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma

47. Genomic characterisation of breast fibroepithelial lesions in an international cohort.

48. MED12 protein expression in breast fibroepithelial lesions: correlation with mutation status and oestrogen receptor expression

49. Genomic landscapes of breast fibroepithelial tumors

50. Whole‐exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1

Catalog

Books, media, physical & digital resources